127 Startups
  • Sector
  • Participated in
  • Year of participation

Ubiq

  • 2009
  • Enabling Technology
  • Other
drug discovery in the ubiquitin field

UFO Biosciences

  • 2019
  • Enabling Technology
  • Venture Challenge
Targeting the cells that matter, enabling better cancer care. By identifying, selecting and isolating single cells, UFO Biosciences enables the identification of the important genes that are missed with current technology.

UpyTher

  • 2017
  • Therapeutics
  • Venture Challenge
UPyTher’s mission is to provide custom drug delivery solutions that enable sustained localized administration of therapeutics.

VEO

  • 2023
  • Enabling Technology
  • Venture Challenge
By exploiting human organoids, VEO enhances the predictive value of antiviral testing over the current pre-clinical models.

VivArt-X

  • 2021
  • Therapeutics
  • Venture Challenge
VivArt-X develops synthetic support material for specific cell therapies. Our lead indication will revolutionize breast reconstructive surgery in women who have undergone breast tissue removal after breast cancer diagnosis.

X-heal Diagnostics

  • 2017
  • Diagnostics
  • Venture Challenge
The ambition of X-Heal Diagnostics is to improve lung health through fast, specific and non-invasive diagnosis of lung infections in different patient groups including chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF) and tuberculosis patients.

YourRythmics

  • 2012
  • Medical Device
  • Other
YourRhythmics develops a medical device that generates a standard ECG, esophageal ECG and reduced BSPM.